Tapestry, Inc. CapEx decreased by 15.6% to $36.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.1%, from $30.90M to $36.80M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a 1.4% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $47.10M | $33.40M | $38.30M | $3.40M | $18.80M | $27.30M | $81.50M | $40.80M | $34.60M | $20.90M | $22.80M | $19.00M | $46.20M | $25.60M | $30.90M | $30.90M | $35.30M | $32.40M | $43.60M | $36.80M |
| QoQ Change | — | -29.1% | +14.7% | -91.1% | +452.9% | +45.2% | +198.5% | -49.9% | -15.2% | -39.6% | +9.1% | -16.7% | +143.2% | -44.6% | +20.7% | +0.0% | +14.2% | -8.2% | +34.6% | -15.6% |
| YoY Change | — | — | — | — | -60.1% | -18.3% | +112.8% | >999% | +84.0% | -23.4% | -72.0% | -53.4% | +33.5% | +22.5% | +35.5% | +62.6% | -23.6% | +26.6% | +41.1% | +19.1% |